Molecular Diagnostics Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

 
 
Purchase Report
To purchase this report, please request an invoice using the 'contact us' form.
 
Date:03/10/2016
Pages:309
Customer Support
+44 (0)1487 843 722

If you have any questions regarding this
report, please call us on the number.

 
Untitled Document

This new report gives a comprehensive and easy-to-review analysis of the molecular diagnostics market for the period 2016 -2020. The report provides key market information and identifies new and emerging opportunities across this growing field. Its findings enable suppliers to reduce costs, drive sales and compete more effectively in the global marketplace.

Laboratory Markets Limited has completed a comprehensive global market study of molecular diagnostics, covering established, recently developed and more specialised methods used in both clinical and clinical research settings. This market analysis reviewed 75,000 clinical and clinical research molecular studies across more than 23,000 clinical and research organisations, encompassing 13 global regions and 125 countries. This identified 12,500 molecular diagnostics laboratories, which were profiled as part of Molecular Diagnostics 2016. Details of these end-user organisations by name are provided as part of this report.

These new findings are the result of a detailed three-year market study by Laboratory Markets Limited, covering the period up until May 2016. These leading market data are combined and analysed alongside findings on the growth and costs of molecular diagnostics from five four other independent market studies, carried out by Laboratory Markets Limited. These five (separate) studies involved the participation of more than 1,700 molecular diagnostics end-users, details of which are also provided with this report.

The clinical and research molecular studies reviewed as part of Molecular Diagnostics 2016 were carried out by experienced molecular biology end-users. These end-users are important decision-makers in the selection and purchase of molecular diagnostics products and services and these 'real world' market data give in-depth information on the current and future use of molecular diagnostics, in addition to % growth, costs, trends and opportunities.

End-user organisations by name are identified in all key molecular diagnostics sectors and segments of this market study. Findings are provided as a PDF report, together with the full Molecular Diagnostics 2016 market database created and compiled during this extensive market study. The data provided enables molecular diagnostics suppliers to easily and rapidly identify, analyse and profile areas of the molecular diagnostics market that offer the greatest business opportunities to their own companies.

The extensive market database provided with the report augments the detailed market findings presented in the PDF report, allowing rapid and easy in-depth analysis across all molecular diagnostics markets. This database can be shared across all departments and subsidiaries of purchasing organisations.

These new study findings provide a considerable wealth of market information to suppliers in the molecular diagnostics and molecular biology fields. They assist suppliers in identify new molecular diagnostics market opportunities and give powerful strategic insights into new developments and applications.

Companies mentioned

A&A Biotechnology, AB ANALITICA, Abbott, Abcam, AccuGenomics, AdnaGen, AdvanDx, Affymetrix, Agendia, Agilent, Ameripath, Amoy Diagnostics, Amplisens, Analytik Jena, Apex, Applied BioCode, Applied BioSystem, Arcxis Biotechnologies, Argene, Inc (Biomerieux), Arrayit, Asuragen, Atlas Genetics, AutoGenomics, Axygen (Corning), Bayer, Beckman Coulter, Becton-Dickinson, Biocartis, Biocept, Biodynamics, Biodyne, Biofire, BioGenex, Biognost, BioGX, BioHelix, Bioline, Biomerieux, Biometra, Bioneer, Bio-Rad, bioTheranostics (AviaraDx), Biotools, Biozyme, Cancer Genetics, Caris Life Sciences, Ceeramtools, Cell Signaling Technology, Cell-marque, Cepheid, Chronix Biomedical, CIS Bioassays, Clarient, Clontech, Conda, Cooperative Diagnostics, Coris-Bio, Cytocell, Da An Gene, Dako (Agilent), DermTech, Diasorin, DNA Technology, ELITech Molecular, Empire Genomics, Enzynomics, Epicentre, Epigenomics, Eppendorf, ESCO, Euroclone, Eurofins, Eurogentec, Euroimmun, Experteem, Falcon Genomics, Fast track Diagnostics, Fermantas, Fermentas, Fisher Biotech, Fisher Scientific, Fluidigm, Focus Diagnostics, Foundation Medicine, GE Healthcare, Gen Probe, Genesearch, Geneworks, GenMark Diagnostics, Genomica, Gen-Probe, Gold Standard Diagnostics, Hain Life Science, Hemogenomics, Hologic, Hylabs, Idaho, IDEXX, IDVET, Illumina, INEP, Integrated Biotherapeutics, Integrated Data Technologies (IDT), IntelligentMDx, Interpath, Invitrogen, Ipsogen (Qiagen), IQuum, Kapa Biosystems, Kreatech Diagnostics, Lectinity, Leica, LGC, Life Technologies, LKB, Luminex, Macherey-Nagel, MDxHealth, Merck Millipore, Meridian Bioscience, Metabion, Millipore, MJ Research, Mobio, MolecularMD, MRC-Holland, MWG Biotech, Myriad Genetics, Nanosphere, NeoGenomics, New England Biolabs, Novagen, Novartis, Olerup SSP, Omega Bio-Tek, Optigene, Orion Genomics, Ortho-Clinical Diagnostics, OvaGene Oncology, Oxoid, Palex, Pathology, Perkin Elmer, Primer Design, PrimeraDx, Promega, Qiagen, Quanta Biosciences, Quidel, R-Biopharm Inc, Ribomed, Roche, Sacace Biotechnologies, Santacruz, Scientifix, Seegene, Seeplex, SensiGen, Serosep Ltd, Siemens, Sigma-Aldrich, Sigma-Genosys, SinaGen, Stratagene (Agilent), Synbiotics, Sysmex, Takara, Thermo Fisher, TiBMolBiol, Ventana (Roche), Vircell, Virion, vivantis, VWR, Zeiss, Zymo

Key Features

Enables suppliers to profile key areas of molecular diagnostics markets relating to their own products and services and provides qualified prospects by end-user organisation name 2) Analyses and ranks molecular diagnostics practices by country, organisation type, methods, diseases, clinical research areas, viruses, bacteria and others, helping suppliers to identify 'high opportunity' sectors relevant to their current molecular diagnostics products and future plans in these fields, supporting targeted marketing and reducing costs and risks 3) Provides key information in growing and developing areas of the molecular diagnostics market, helping suppliers focus resources on molecular diagnostics growth areas, supporting new sales opportunities in important market sectors 4) Helps suppliers to evolve and extend their own strategic visions, future plans and operational activities in the molecular diagnostics field 5) Enables suppliers to identify, analyse and rank end-user practices and needs and build new customer relationships in leading molecular diagnostics market sectors.

Molecular Diagnostics Market Study
This study provides detailed market data on the use of molecular diagnostics across all global regions, covering more than 125 countries. Leading countries in terms of molecular diagnostics use are also identified, together with top users by state or county, city and organisation name.
Molecular Diagnostics 2016 identified more than 12,500 molecular diagnostics end-user laboratories, each of which are profiled across key market areas, allowing the analysis of all key sectors, developments and opportunities in this field.
Organistion using molecular diagnostics are profiled as part of this study including hospitals, clinics, health centres and and companies. relevent organisation departments are also identified.
More than 100 molecular diagnostics methods are profiled, from those most commonly used such as qPCR and RT-PCR through to newer or more specialised methodologies such as digital PCR and sequencing.
The PDF report provides an in-depth analysis of key findings across all major sectors, and identifies key sector developments and opportunities, growth and end-user costs in this diverse and growing field.
Key molecular diagnostics market areas have been profiled including global regions, countries, country states/counties, cities, end-user organisations, methods, applications, diseases, viruses, bacteria and other areas.
These findings assist suppliers in the molecular diagnostics fields to keep pace with end-users' laboratory activities and needs. They also offer a highly cost-effective source of marketing and sales related information and give new insights into today's evolving clinical diagnostics fields.
   
Molecular Diagnostics Market Database
The Molecular Diagnostics 2016 database contains more than 34,500 individual records of molecular diagnostic studies, including 12,500 molecular diagnostics laboratories by name from studies reported betweeen January 2013 and May 2016.
This datebase is provided as an easy-to-use Excel file which can be rapidly analysed using Pivot Tables. This allows tables and graphs of all molecular diagnostics market sectors or segments to be easily generated in minutes.
Pivot table analysis allows the analysis of molecular diagnostics market data across all segments, allowing established methods to be analysed, as well as newer developments and market opportunities.
Data contained in the Molecular Diagnostics 2016 database allows side-by-side comparisons of current and developing practices across key sectors of this market.
The database can be shared across all subsiquaries of purchasing organisations. This allows data analysis from multiple perspectives, from marketing and sales through to R&D and new product innovation.
This database enables easy analysis of molecular diagnostics practices from the methods and applications end-users are running, to more powerful analyses of relationships in the market, offering market predictions and trend analysis.
The market data presented in the Molecular Diagnostics 2016 database provides a valuable source of qualified sales prospects, based on the current and developing use of molecular diagnostics across multiple organisations and sectors.


Molecular Diagnostics 2016 Market Study

1. Molecular Diagnostics Laboratories

This market study covers more than 12,500 molecular diagnostics end-user laboratories globally, which are identified by organisation name and department, country and in most cases, by city. The top molecular diagnostics end-users (based on the numbers of reported molecular diagnostics studies) can be identified, as well as the 'top growers' based on the numbers of molecular diagnostic studies. These data enable suppliers to identify sales prospects and opportunities based on current use and market developments and trends. Findings on individual molecular diagnostics laboratories can be segmented across all areas of the study.

2. Molecular Diagnostics Methods

Findings on individual molecular diagnostics methods can be segmented across all areas of the study versus other molecular diagnostics methods, molecular diagnostics utilities, clinical and clinical research use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

The molecular diagnostics methods identified and profiled in this study include (in alphabetical order) ACB-PCR, Allele-specific PCR, Amplification by PCR, AP-PCR, ARMS-PCR, Assembly PCR, Asymmetric PCR, Breakpoint PCR, Chip PCR, ChIP-PCR, Classical PCR, COLD-PCR, Colony PCR, dcRT-MLPA, Differential DNA Denaturation PCR, Digital PCR, DMAMA PCR, DOP-PCR, duplex RT-PCR, eHT-PCR, ERIC-PCR, FAP PCR, FLASH-PCR, Flow Through PCR, FRET PCR, Fusion PCR, Gap PCR, Helicase-Dep Amplification, HRM PCR, ICE-COLD-PCR, Immunocapture PCR, Inverse PCR, Isothermal PCR, LAMP, LA-PCR, Ligation-Mediated PCR, Linker-Adapted PCR, Long PCR, MAMA-PCR, MAP PCR, MDA-PCR-SBT, Methylation-Sensitive AP PCR, Methylation-Specific PCR, Microsphere-Based Array, MLPA, MS-MLPA, Mult displ Amplification, Multiplex PCR, Multiplex qPCR, Multiplex RT-PCR, Multiplex Taqman, Mut Sep PCR, NASBA, Nested PCR, One-step multiplex qRT-PCR, Overlap extension PCR, Overlap PCR, Panbacterial PCR, PCR array, PCR ELISA, PCR Fingerprinting, PCR Screening, PCR Sequencing, PCR SSP, PCR targeting, PCR testing, PCR-based screening, PCR-DGGE, PCR-fluorescence probe, PCR-free MPS library prep, PCR-LDR, PCR-RFLP, PCR-SBE, PCR-SSO, PCR-SSOP, PCR-SSP, PCR-targeted sequencing, PMA-qPCR, Polymerase Cycling Assembly, Polymorphism-PCR, qPCR, qRT-PCR, RACE-PCR, RAPD PCR, rep-PCR, RFLP-PCR, RFQ-PCR, RNA PCR, RNA-Seq, RNA-Specific PCR, RT-MLPA, RT-PCR, rzPCR, Single cell PCR, SOE PCR, Solid Phase PCR, Species specific PCR, specific-to-allele PCR-FISH, SSP-PCR, TAIL-PCR, Taqman PCR, Taqman qPCR, T-ARMS PCR, Touchdown PCR, Trap PCR, Trap PCR ELISA, TTGE PCR and Type-Specific PCR.

3. Molecular Diagnostics Utilities

This study identified molecular diagnostics utilities, which are presented in this report. While applications such as gene expression and mutation analysis are important established utilities of molecular diagnostics, findings in this study enable the relative importance of each of the utilities/applications to be analysed and profiled.

Findings on individual molecular diagnostics utilities can be segmented across all areas of the study (versus molecular diagnostics methods, molecular diagnostics utilities, clinical and research clinical use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Molecular Diagnostics applications identified in this study are (in alphabetical order) Allele frequencies, Allele size, Amplification, Antibiotic resistance, Antimicrobial susceptibility, Antiseptic resistance, Antiviral Resistance, Apoptosis, Bacteria identification, Bacterial concentrations, Bacterial DNA, Bacterial Load, Bacterial populations, Bacterial sensitivity, Bacterial Strains, Biomarkers, Blood screening, Cell cycle, Cell expression, Cell Lysis, Chromosome abnormalities, Chromosome analysis, Clinical Therapeutics, Clonal relationships, Cloning, Commensal bacteria, Community profiling, Cytogenetic, Cytokines, Degree of homology, Diagnosis, DNA analysis, DNA breakage, DNA copies, DNA damage, DNA degradation, DNA levels, DNA methylation, DNA ploidy, DNA profiling, DNA quantification, DNA sequencing, DNA-barcoding, Drug resistance gene, Environmental monitoring, Epidemiology, Fingerprinting, Food testing, Gene abundance, Gene alterations, Gene assay, Gene copies, Gene deletions, Gene detection, Gene down-regulation, Gene expression, Gene fusion, Gene Identification, Gene interactions, Gene Knockdown, Gene level, Gene Methylation, Gene mutations, Gene overexpression, Gene polymorphism, Gene regulation, Gene variants, Genetic disease, Genetic mapping, Genomic DNA, Genomics, Genotyping, Haplotypes, Host-pathogen interactions, Infections, Infectious bacteria, infectious disease, Karyotyping, Leukocyte telomere length, Metagenomics, Microarray, Microbial identification, Microbiota, MicroRNA, Microsatellite, Microsatellite typing, Mitochondrial DNA, Mobile elements, Molecular characterization, Molecular tests, Monoclonality, mRNA, Mutations, New viruses, Outbreak investigation, Patient monitoring, PCR tests, Phylogenetic analysis, Population dynamics, Prognosis, Quantitation of viruses, Rapid tests, Receptor expression, Recombinant DNA, Residual disease, Resistance, Resistance genes, RNA quantification, RNA sequence analysis, Screening, Senescence, Sequence-tagged sites, Serotyping, Signaling pathway, Single nucleotide polymorphism, Single nucleotide repeats, siRNAs, Site-directed mutagenesis, Species identification, STR typing, Strain detection, Strain typing, Telomerase, Tissue expression, Tissue typing, Transcript detection, Transcript levels, Transcript numbers, Transcript quantification, Transcriptional activities, Transcriptional regulators, Transcriptome, Transcripts, Translocations, Treatment decisions, Tumor-associated genes, Upregulations, Vaccination, Vector borne pathogens, Veterinary, Viral DNA, Viral load, Viral replication, Viral RNA copies, Viral Strains, Viral typing, Viral vector, Virulence factors, Virulence genes, Virulence traits, Virus concentrations, Virus detection, Virus genes, Virus subtypes, Viruses and Water safety

4. Other Molecular Methods

Other molecular methods and related used alongside other molecular diagnostic methods are also profiled as part of this study. More than 50 other molecular methods are profiled in this study from commonly used Western blot and microarray, through to gene-knockout and CRISPR.

Findings on other molecular methods can be segmented across all areas of the study versus molecular diagnostics methods, molecular diagnostics utilities, clinical and research use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Other molecular methods identified include (in alphabetical order) alanine scanning, ATAC-seq, ChIA-PET, ChIP-exo, ChIP-on-chip, ChIP-sequencing, Chromatin immunoprecipitation, Cloning, Comet assay, Comparative Genomic Hybridization Array, CRISPR, Cycling Probe, Diversity Array Technology, DNA cloning, DNA footprinting, DNA Methylation Array, DNA microarray, DNA Patterns, DNA sequencing, DNase-Seq, Electrophoresis, Electrophoretic mobility shift assay, Exome sequencing, Exon arrays, Far-western blotting, Fluorescence in-situ hybridization, Förster resonance energy transfer, Gene Array, Gene knockout, Immunoprecipitation, In Situ Hybridization, Ion Torrent, Karyotyping Massively Parallel Signature Sequencing, Microarray, Microsatellite enrichment, miRNA Array, Multilocus Sequence Typing, Mutagenesis, Next-Generation Sequencing, Northern blot, Nuclease protection assay, Oligonucleotide Array, Oligotyping, Photoaffinity labeling, Plasmidome, Pyrosequencing, Ribosomal Intergenic Spacer analysis, Ribosome profiling, Sanger sequencing, Shotgun Sequencing, Southern blot, Southwestern blot, STable-isotope probing, Strand Displacement Amplification, Strep-tag, Subcloning, Suspension array technology, Taqman Array, Tiling Array, Transcriptome Array, Viability assay, Western blot and Yeast two-hybrid,

5. Diseases

Findings from this study enable suppliers in the molecular diagnostics and molecular biology fields to identify and profile laboratories where molecular diagnostics are used in specific disease areas. Findings on disease areas can be segmented across all areas of the study versus molecular diagnostics methods, molecular diagnostics utilities, clinical and clinical research use, other diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

More than 1,100 disease areas have been investigated and these include (in alphabetical order) AIDS, Alzheimer's Disease, Antibiotic Resistance, Asthma, Autoimmune Disease, Avian Influenza, Cancer–Bladder, Cancer–Breast, Cancer–Cervical, Cancer–Colon, Cancer–Endometrial, Cancer–Gastric, Cancer–Leukaemia, Cancer–Liver, Cancer–Lung, Cancer–lymphoma, Cancer–Oesophageal, Cancer–Ovarian, Cancer–Pancreatic, Cancer–Prostate, Cancer–Rectal, Cancer–Thyroid, Cancer–Ovarian, Cholera, COPD, Coronary Artery Disease, Cystic Fibrosis, Diabetes mellitus, Diabetes Type 1, Diabetes Type 2, Diarrhoea, Drug Resistance, Encephalitis, Endometriosis, Epilepsy, Gastroenteritis, Glioblastoma, Glioma, Heart Disease, Heart Failure, Hepatitis B, Hepatitis C, Hepatocellular Carcinoma, Hypertension, Hypoxia, Immunodeficiency, Infertility, Inflammatory Bowel Disease, Influenza A, Influenza B, Insulin Resistance, Kidney Disease, Leishmaniasis, Liver Cirrhosis, Liver Disease, Malaria, Melanoma, Meningitis, Metabolic Syndrome, Metastases, Multiple Myeloma, Myeloid Leukemia, Myocardial Infarction, Myopathy, nasopharyngeal carcinoma, Nephropathy, Neuroblastoma, Osteoarthritis, Osteoporosis, Osteosarcoma, Pancreatitis, Parkinson's Disease, Periodontal disease, Pneumonia, Polycystic Ovary Syndrome, Psoriasis, Pulmonary Fibrosis, Renal cell carcinoma, Renal Disease, Renal failure, Retinoblastoma, Retinopathy, Schizophrenia, Sclerosis, Skin lesion, Spinal cord injury, Squamous Cell Carcinoma, Stroke, Systemic Lupus, Thrombocytopenia, Toxoplasma, Toxoplasmosis, Trachoma, Traumatic brain injury, Tuberculosis, Urothelial carcinoma, Uveitis, Varicella, Vascular Disease, Visceral leishmaniasis and Vomiting,

6. Clinical and Clinical Research Use

All molecular diagnostics studies cited in this report were reviewed to establish the clinical or research clinical use of these methods. These findings cane be segmented across all areas of the study versus other molecular diagnostics methods, molecular diagnostics utilities, clinical and research clinical use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

7. Nucleic Acid Types

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific nucleic acid types. Findings on nucleic acid types can be segmented across all areas of the study versus other molecular diagnostics methods, molecular diagnostics utilities, clinical and clinical research use, diseases, virus and bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Around 75 nucleic acids types have been investigated and these include (in alphabetical order) 12S rRNA, 16s ribosomal RNA, 16S rRNA, 16S-23S rRNA, 16SrDNA, 18S rDNA, 23S rRNA, 3CDR3 DNA, Archaeal DNA, Archived DNA, Bacterial DNA, B-cell DNA, Bisulfite-converted DNA, Blood DNA, ccfDNA, cDNA, Cell-free DNA, cfDNA, Chromosomal DNA, Circular DNA, Circulating DNA, Circulating nucleic acids, Circulating RNA, Circulating tumor DNA, ctDNA, DNA, DNA extraction, DNA extracts, DNA hypermethylation, DNA isolation, DNA markers, DNA methylation, Fetal DNA, Fish DNA, Fungal DNA, Genomic DNA, HIV-1 DNA, HPV DNA, HPV-16 DNA, HSV DNA, kDNA, Kinetoplast DNA, Leukocyte DNA, MicroRNA, miRNA, Mitochondrial DNA, mRNA, mtDNA, Noncoding RNA, Nuclear DNA, Parasite DNA, Pathogen DNA, piRNA, Plasmid DNA, Polymorphic DNA, Proviral DNA, Ribosomal RNA, RNA, RNA analysis, RNA extraction, rRNA, Single stranded DNA, siRNA, Small interfering RNA, Small nuclear RNA, snRNA, ssDNA, T-DNA, Total RNA, Transfer RNA, tRNA, Viral DNA, Viral RNA and Virus-specific DNA,

8. Viruses

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific virus types. Findings on virus types can be segmented across all areas of the study versus other molecular diagnostics methods, other molecular diagnostics applications, clinical and research use, diseases, other viruses, bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Around 390 virus types have been investigated and these include (in alphabetical order) African swine fever virus, Avian leukosis virus, Beak and feather disease virus, Betacoronavirus, Bluetongue virus, Bombyx mori nucleopolyhedrovirus, Bovine leukemia virus, Bovine viral diarrhea virus, Canine distemper virus,Cauliflower mosaic virus, Chicken anemia virus, Chikungunya virus, Citrus tristeza virus, Classical swine fever virus, Coronavirus, Cucumber mosaic virus, Cyprinid herpesvirus, Cytomegalovirus, Dengue virus, Duck circovirus, Enterovirus, Epstein-Barr virus, Equid herpesvirus, Feline calicivirus, Feline immunodeficiency virus, Feline leukemia virus, Foot-and-mouth disease virus, Frog virus, Gammapapillomavirus, Hepatitis, Herpes simplex, HIV, Hop stunt viroid, Human coronavirus, Human herpesvirus, Human metapneumovirus, Human papillomavirus, Human polyomavirus, Human respiratory syncytial virus, human T-lymphotropic virus, Infectious bursal disease virus, Infectious hematopoietic necrosis virus, Infectious pancreatic necrosis virus, Influenza, Japanese encephalitis virus, JC polyomavirus, Lymphocystis disease virus, Mamastrovirus, Measles virus, Mouse mammary tumor virus, Mumps virus, Murine leukemia virus, Newcastle disease virus, Nipah virus, Norwalk virus, Orf virus, Ostreid herpesvirus, Ovine herpesvirus, Parainfluenza virus, Parapoxvirus, Parechovirus, Parvovirus, Pegivirus, Pepper mild mottle virus, Polyomavirus, Porcine circovirus, Porcine epidemic diarrhea virus, Porcine reproductive and respiratory syndrome virus, Potato virus, Puumala virus, Rabies virus, Respiratory syncytial virus, Reticuloendotheliosis virus, Rice stripe virus, Rift Valley fever virus, Rotavirus, Rubella virus, Sacbrood virus, Salivirus, Sendai virus, Seoul virus, Simian foamy virus, Simian immunodeficiency virus, Simian virus, Sindbis virus, Suid herpesvirus, Tembusu virus, Tick-borne encephalitis virus, Tobacco mosaic virus, Tobacco rattle virus, Tomato torrado virus, Tomato yellow leaf curl virus, Torque teno virus, Triatoma virus, Vaccinia virus, Varicella Zoster, Viral hemorrhagic septicemia virus, West Nile virus, White spot syndrome virus, Yellow fever virus and Zika virus.

9. Bacteria

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific bacterial types. Findings on bacteria types can be segmented across all areas of the study versus other molecular diagnostics methods, other molecular diagnostics utilities, clinical and clinical research use, diseases, viruses, other bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Around 710 bacteria types have been investigated and these include (in alphabetical order; Genus or Genus+Species) Acinetobacter baumannii, Actinobacteria, Aeromonas hydrophila, Aggregatibacter actino-mycetemcomitans, Agrobacterium, Agrobacterium tumefaciens, Anaplasma phagocytophilum, Bacillus subtilis, Bacillus thuringiensis, Bordetella pertussis, Borrelia, Borrelia burgdorferi, Brucella, Campylobacter, Campylobacter jejuni, Cardiobacterium hominis, Chlamydia, Chlamydia trachomatis, Clostridium, Clostridium difficile, Clostridium perfringens, Coxiella burnetii, Cyanobacteria, Ehrlichia canis, Enterobacter, Enterococcus, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Firmicutes, Flavobacterium, Francisella tularensis, Haemophilus influenzae, Helicobacter, Helicobacter pylori, Klebsiella pneumoniae, Lactobacillus, Lactobacillus plantarum, Lactococcus lactis, Legionella, Legionella pneumophila, Leptospira, Leptospira interrogans, Leuconostoc van, Listeria monocytogenes, Mycobacteria, Mycobacterium, Mycobacterium avium, Mycobacterium bovis, Mycobacterium leprae, Mycobacterium tuberculosis, Mycoplasma, Mycoplasma pneumoniae, Mycoplasmas, Neisseria gonorrhoeae, Neisseria meningitidis, Nontuberculous, Non-tuberculous mycobacteria, Paenibacillus, Pasteurella multocida, porphyromonas gingivalis, Prevotella, Proteus, Pseudomonas, Pseudomonas aeruginosa, Pseudomonas putida, Pseudomonas syringae, Rhizobia, Rickettsia, Rickettsiae, Salmonella, Salmonella enterica, Salmonella typhimurium, Sarcina, Shigella, Staphylococcus, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, Streptococcus agalactiae, Streptococcus mutans, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus suis, Streptococcus thermophilus, Streptomyces, Treponema, Treponema denticola, Ureaplasma, Ureaplasma urealyticum, Vibrio, Vibrio alginolyticus, Vibrio anguillarum, Vibrio cholerae, Vibrio harveyi, Vibrio parahaemolyticus, Wolbachia, Xanthomonas, Yersinia and Yersinia enterocolitica.

10. Global Regions

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific global regions. Findings on global regions can be segmented across all areas of the study (molecular diagnostics methods, molecular diagnostics utilities, clinical and clinical research use, diseases, virus and bacteria types, other nucleic acid types, other global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, companies, research institutes, medical and research centers, universities, veterinary organisations etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Thirteen global regions have been investigated, namely (in alphabetical order) Asia, Caribbean, Central Africa, Central America, Eastern Africa, Europe, Middle East, North America, Northern Africa, Oceania, South America, Southern Africa and Western Africa.

11. Countries

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific countries. Findings on specific countries can be segmented across all areas of the study versus molecular diagnostics methods, molecular diagnostics utilities, clinical and clinical research use, diseases, virus and bacteria types, other nucleic acid types, global regions, other countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

More than 125 countries have been investigated and these include (in alphabetical order) Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Burkina Faso, Cambodia, Cameroon, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jersey, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Macedonia, Malaysia, Mexico, Morocco, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Palestine, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Republic of Korea, Romania, Russia, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Syria, Taiwan, Tanzania, Thailand, Tunisia, Turkey, Uganda, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam and Zambia.

12. Organisation Types

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics is used relating to specific organisation types. Findings on organisation types can be segmented across all areas of the study versus other molecular diagnostics methods, molecular diagnostics utilities, clinical and clinical research use, diseases, virus and bacteria types, other nucleic acid types, global regions, countries, states or counties, cities, organisation names, other organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

13. Departments

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific end-user departments. Findings on specific departments can be segmented across all areas of the study versus molecular diagnostics methods, other molecular diagnostics utilities, clinical and clinical research use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Around 6800 end-user departments have been investigated and these include (in alphabetical order) Agriculture, Anatomy, Anaesthesiology, Animal Science, Biochemistry, Biochemistry and Molecular Biology, Biological Sciences, Biology, Biomedical Engineering, Biomedical Sciences, Biotechnology, Breast Surgery, Cardiology, Cardiothoracic Surgery, Cell Biology, Chemistry, Civil and Environmental Engineering, Clinical Biochemistry, Clinical Laboratory, Clinical Pathology, Clinical Sciences, Dermatology, Emergency, Endocrinology, Entomology, Epidemiology, Forensic Medicine, Gastroenterology, Gastroenterology and Hepatology, Gastrointestinal Surgery, General Surgery, Genetics, Geriatrics, Gynaecology, Gynaecology and Obstetrics, Hematology, Hepatobiliary Surgery, Histology and Embryology, Human Genetics, Immunology, Infectious Diseases, Internal Medicine, Laboratory Medicine, Life Sciences, Medical Biochemistry, Medical Biology, Medical Genetics, Medical Microbiology, Medical Oncology, Medicine, Microbiology, Microbiology and Immunology, Molecular Biology, Molecular Medicine, Nephrology, Neurology, Neuroscience, Neurosurgery, Obstetrics, Obstetrics and Gynaecology, Obstetrics and Gynaecology, Oncology, Ophthalmology, Oral and Maxillofacial Surgery, Orthodontics, Orthopaedic Surgery, Orthopaedics, Orthopaedic Surgery, Orthopaedics, Otolaryngology, Otolaryngology-Head and Neck Surgery, Otorhinolaryngology, Paediatrics, Parasitology, Pathobiology, Pathology, Pathology and Laboratory Medicine, Pathophysiology, Paediatric Surgery, Paediatrics, Periodontology, Pharmacology, Pharmacy, Physiology, Plant Pathology, Psychiatry, Radiation Oncology, Radiology, Respiratory Medicine, Rheumatology, Stomatology, Surgery, Surgical Oncology, Thoracic Surgery, Urology, Veterinary Medicine, Virology and Zoology

14. States, Counties and Cities

Findings from this study enable suppliers in the molecular diagnostics field to identify and profile laboratories where molecular diagnostics are used relating to specific states and cities. Findings on specific states/counties and cities can be segmented across all areas of the study versus molecular diagnostics methods, molecular diagnostics utilities, clinical and research use, diseases, virus and bacteria types, nucleic acid types, global regions, countries, states or counties, cities, organisation names, organisation types (hospitals, clinics, medical centres etc) and departments. In all cases, the organisations reporting the use of these specific methods are identified by name in this study.

Around 790 states/counties and 3500 cities have been investigated. All leading states/counties and cities are included, each of which can be ranked according to the number of molecular diagnostics studies reported.

14. Molecular Diagnostics Studies

All 19,500+ molecular diagnostics studies are fully referenced, allowing molecular diagnostics end-users to be identified by name alongside further details of their work.

15. Molecular Diagnostics Growth & Costs

Findings from Molecular Diagnostics 2016 are analysed alongside data on market % growth and end-user costs obtained during four other (separate) independent molecular diagnostics studies by Laboratory Markets Limited, provided by more than 1,700 experienced molecular diagnostics end-users.

 

 

  •